1. Home
  2. TMDX vs ARCB Comparison

TMDX vs ARCB Comparison

Compare TMDX & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$78.56

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo ArcBest Corporation

ARCB

ArcBest Corporation

HOLD

Current Price

$142.96

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
ARCB
Founded
1998
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Trucking Freight/Courier Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.7B
IPO Year
2019
1994

Fundamental Metrics

Financial Performance
Metric
TMDX
ARCB
Price
$78.56
$142.96
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$148.22
$122.75
AVG Volume (30 Days)
1.1M
382.3K
Earning Date
05-05-2026
04-28-2026
Dividend Yield
N/A
0.38%
EPS Growth
382.18
N/A
EPS
0.20
N/A
Revenue
$605,494,000.00
$1,657,864,000.00
Revenue This Year
$24.25
$7.00
Revenue Next Year
$18.75
$5.80
P/E Ratio
$394.55
N/A
Revenue Growth
37.13
12.56
52 Week Low
$60.11
$59.43
52 Week High
$156.00
$176.69

Technical Indicators

Market Signals
Indicator
TMDX
ARCB
Relative Strength Index (RSI) 56.11 49.64
Support Level $64.90 $112.62
Resistance Level $120.60 N/A
Average True Range (ATR) 4.22 8.06
MACD 1.88 -1.80
Stochastic Oscillator 87.80 24.73

Price Performance

Historical Comparison
TMDX
ARCB

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: